MedPath

Light Intervention for Adaptation to Night Work

Not Applicable
Completed
Conditions
Sleep Deprivation
Sleep
Shift-Work Related Sleep Disturbance
Interventions
Device: LED-light, 7000 K
Device: LED-light, 2500 K
Device: LED-light, 1000 lux
Device: LED-light, 100 lux
Device: Blue LED-light
Device: Red LED-light
Registration Number
NCT03203538
Lead Sponsor
University of Bergen
Brief Summary

The project will contribute with new knowledge concerning how aspects of the physical work environment (lighting conditions) can be arranged to facilitate the workers' adaptation to night work. This is important given the reported adverse consequences of shift work for performance, safety, and health. The project involves a series of three experimental, laboratory based shift work simulation studies. The aim is to investigate how different lighting conditions (intensities and colour temperature), administered through light emitting diode (LED) based bright light integrated standard room lighting, affects adaptation to three consecutive simulated night shifts and re adaptation to a day oriented schedule on measures of alertness, cognitive performance, sleep and circadian rhythm. The proposed project examines the effects of interventions that can be applied in naturalistic settings and will be based on new laboratory infrastructure available at the laboratories situated in the Faculty of Psychology, University of Bergen.

Detailed Description

Bright light has been suggested as a countermeasure to the negative impact of night work in terms of safety, performance and subsequent sleep. The effect depends on the timing of light (e.g, phase-response curve), duration of light exposure and the intensity of light, as well as the wavelengths that are emitted. Exposure to bright light (more intense than typical room lightning), at evening and night, has been effective in delaying the circadian rhythm to sufficiently adapt to night work both in simulated night work, and in field studies of workers. Blue light has significantly stronger phase shifting effects than other wavelengths of the visible spectrum. The effect of light on the circadian system is mediated by retinal photoresponsive cell population (intrinsically photoresponsive retinal ganglion cells; ipRGC) that contains the photopigment melanopsin, highly sensitive to blue light. These cells signal directly to the suprachiasmatic nuclei (SCN) of the hypothalamus, the circadian pacemaker. Bright light has also been reported to improve alertness and performance during night shifts.

To the best of the investigators knowledge, no shift work simulation study has made the full advance of LED-technology in terms of using light administered via standard room lighting on adaptation to night work. Today, new LED-technology represents an excellent opportunity to study this as roof mounted LED-sources integrated as standard indoor lightening can be programmed to provide a wide range of light intensities and colour temperatures. LED-sources have the advantage over standard light therapy that subjects can be exposed to the therapy via standard room lightening (not confined to a special therapy lamp) thereby allowing the workers to conduct work tasks as normal during light exposure.

Against this backdrop this project aims to investigate how different lighting conditions, administered through LED-based bright light integrated standard room lighting, affects adaptation to three consecutive simulated night shifts and re adaptation to a day oriented schedule on measures of alertness, cognitive performance, sleep and circadian rhythm. In addition, measures of mood, appetite, heart rate variability (HRV), pain sensitivity, moral reasoning, and inflammatory markers will be examined. The researchers also aim to investigate the effects of two extreme monochromatic light conditions (blue vs. red) based on integrated standard room lighting on the adaptation to one simulated night shift.

Study participants will work simulated night shifts (11:00 pm to 07:00 am) in a light laboratory where light parameters (intensity and colour temperature) can be manipulated via roof mounted LED-sources integrated as standard indoor lightening. Participants will be recruited among students at the University of Bergen, and a screening will be done to ensure healthy participants fit for the study. The included participants will take part in experiments with two bouts of three consecutive simulated night shifts (6 nights in total).

HRV will be measured throughout the night shift, and five times, approx. every 1.5 hour (11:30 pm, 01:00 am, 02:30 am, 04:00 am, 05:30 am), the subjects will be tested on a test battery of cognitive tests and will rate their subjective sleepiness. Sleep will be assessed by sleep diary and actigraphy 3 days prior to, during, and 3 days following the shifts. One day before the night shift and the day after the night shift period the circadian rhythm will be measured by saliva samples for estimation of dim light melatonin onset. Prior to-, during- and after the night shifts, participants will undergo a pain sensitivity test. Blood spot samples will be collected at the beginning and the end of each night shift for analysis of inflammatory markers (e.g. interleukins).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • Participants are physical and mentally healthy (assessed with BMI and 'General Health Questionnaire-12')
  • Participants accept to comply with the protocol (refrain from alcohol, tobacco and coffee, and retain regular bed- and wake-times the week before the simulated night shifts)
Exclusion Criteria
  • Neurological, psychiatric or sleep related disorders ('Bergen Insomnia Scale', 'global sleep assessement questionnaire')
  • Extreme 'morningness-eveningness' type ('Horne Östberg morningness eveningness questionnaire')
  • Use of medication
  • Worked night shifts the last 3 months
  • Travelled through more than two time zones the last 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Colour temperature, 7000 KelvinLED-light, 7000 KParticipants will work three consecutive simulated night shifts under full-spectrum LED-light, 7000 K (200 lux) administered through standard room lighting.
Colour temperature, 2500 KelvinLED-light, 2500 KParticipants will work three consecutive simulated night shifts under full-spectrum LED-light, 2500 K (200 lux) administered through standard room lighting.
Light intensity, 1000 lux (4000 K)LED-light, 1000 luxParticipants will work three consecutive simulated night shifts under full-spectrum LED-light, 1000 lux (4000 Kelvin) administered through standard room lighting.
Light intensity, 100 lux (4000 K)LED-light, 100 luxParticipants will work three consecutive simulated night shifts under full-spectrum LED-light, 100 lux (4000 Kelvin) administered through standard room lighting.
Blue light, 455 nmBlue LED-lightParticipants work one night shift with blue LED-light (peak wavelength 455 nm) administered through standard room lighting.
Red light, 615 nmRed LED-lightParticipants work one night shift with red LED-light (peak wavelength 615 nm) administered through standard room lighting.
Primary Outcome Measures
NameTimeMethod
Circadian phase5 days-nights

Circadian phase will be measured through assessement of 'Dim Light Melatonin Onset' (DLMO). Saliva samples will be collected every hour in the evening (from 7 pm) to one hour past regular bedtime, one day before the first night shift and the day after the night shift period. Saliva will be analyzed for melatonin, giving an estimate on DLMO.

Sleep9 days-nights

Sleep will be measured objectively using actigraphy

Cognitive performance3 nights

Cognitive performance will be measured using the Psychomotor Vigilance Test (PVT). The PVT measures sustained attention, and is considered the 'gold standard' for assessing the effects of sleep deprivation on cognition. The task will be performed approx. every 1.5h throughout the nightshifts.

Secondary Outcome Measures
NameTimeMethod
Heart rate variability3 nights

'Heart Rate Variability' will be assessed by using Polar heart rate monitor V800 that will continuously monitor 'HRV' through the night.

Core body temperature1-2 nights

To get a secondary measure of circadian phase, core body temperature will be measured using ingestible temperature capsules.

Experiences of perceptual anomalies3 nights

The Cardiff Anomalous Perceptions Scale (CAPS) questionnaire will be administered after the night shifts to assess experiences of hallucinations and perceptual anomalies during night shifts. The questionnaire consists of 32 items/questions regarding perceptual anomalies, e.g. "Do you ever notice that sounds are much louder than they normally would be?", that are answered with 'yes' or 'no'. Adding up the number of 'yes' answers gives the CAPS Total Score ranging from 0 (low) to 32 (high). For each item endorsed, participants rate the item for distress, intrusiveness and frequency, giving three subscales. The rating for subscales goes from 1 (low) to 5 (high). Nonendorsed items are considered to have a score of 0 on subscales. For each subscale the possible range goes from 0 (low) to 160 (high).

Self-reported sleep9 days-nights

A sleep diary will be used.

Interleukin3 nights

Blood spot samples will be analyzed for interleukins (IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-13)

Granulocyte macrophage colony-stimulating factor (GM-CSF)3 nights

Blood-spot samples will be analyzed for GM-CSF.

Headache and eyestrain3 nights

A 'Headache and Eyestrain Scale' will be used to get subjective measures on how participants perceive the lighting conditions.

Decision/ response execution3 nights

A 'Two-Choice Numerosity Discrimination Task' measure decision criterion and response execution

Decision/ response inhibition3 nights

A 'Reversal Learning Decision Task' measure ability to adjust choices/ response inhibition

Moral reasoning3 nights

the 'Defining Issues Test' measure moral reasoning.

Leadership evaluation2 nights, 1 day

The 'Multifactor Leadership Questionnaire' will be used to assess participants leadership preferences. The questionnaire will be administered during daytime and during night shifts.

Pain sensitivity3 nights

By using a handheld pressure algometer, Wagner FPIX Force One, the pressure pain threshold will be measured. The test site will be the trapezius muscle, and the pressure will be increased in steps of 5 N/sec until the participant indicates pain.

Working memory3 nights

A 'Working Memory Scanning Task' measure ability to encode and maintain information in working memory

Cognitive throughput3 nights

A 'Digit Symbol Substitution Test' will be used as a measure of cognitive throughput

Fine motor skills3 nights

The 'grooved pegboard test' assess fine motor skills through the night shifts

Recognition of emotions3 nights

An 'emotional hexagon test', were participants rate standardized pictures of faces expressing different emotions, measure the ability to discriminate between emotional expressions.

Objective sleepiness, sleep and sleep stages3 nights and sleep periods

A subgroup of participants (12-16 in each experiment) will be subject to electroencephalography (EEG) during night shifts, and polysomnography (PSG) after night shifts. EEG will provide a measure of electrical activity in the brain during wakefulness, and can provide an objective measure of sleepiness. PSG will be conducted in the sleep period after night shifts, and allow for the scoring of sleep stages. PSG is considered the gold standard for measuring sleep.

Subjective sleepiness3 nights

Karolinska Sleepiness Scale (KSS) will be used to assess subjective sleepiness throughout the night shifts. KSS is a likert scale ranging from 1-9, where subjects rate their sleepiness. '1' indicates 'extremely alert', '9' indicates 'very sleepy/fighting sleep'.

Interferon gamma (IFN-gamma)3 nights

Blood-spot samples will be analyzed for IFN-gamma.

Tumor necrosis factor alpha (TNF-a)3 nights

Blood-spot samples will be analyzed for TNF-a

Positive and negative affect3 nights

'Positive and Negative Affect Schedule', will be administered to assess mood.

Appetite/ food cravings3 nights

Appetite/ food cravings for different food types will be assessed using a visual analogue scale to record response to questions like: "How much would you like to eat xxx right now?"

A 'Dot-probe test' provides measure of attentional bias towards various food types (pictures)

Cognitive control3 nights

A 'Task Switching-Performance Test' measure cognitive control

Planning3 nights

The 'Tower of Hanoi Test' measure planning and sequencing abilities

Pupil size3 nights

Pupil size will be measured, using a tobii eyetracker, three times during night shifts. This can provide an objective measure of sleepiness.

Trial Locations

Locations (1)

The faculty of psychology, University of Bergen

🇳🇴

Bergen, Hordaland, Norway

© Copyright 2025. All Rights Reserved by MedPath